How Much Is Versus Medici Worth?
Last updated: June 1, 2026
Quick Facts
- Last Sale
- $50.8M (2021, Sotheby's, New York)
- Methodology
- recent sale
Anchored to the confirmed Sotheby’s auction of Versus Medici (May 12, 2021; price realized USD 50,820,000), this valuation places the work in a market‑sellable range of USD 45–70 million for a marquee evening‑sale offering. The lower bound assumes a well‑presented lot in a standard sale; the upper bound reflects optimal conditions (impeccable condition, expanded provenance/exhibition documentation, strong competitive bidding or institutional interest).

Versus Medici
Jean-Michel Basquiat, 1982 • Acrylic, oilstick and paper collage on three joined canvases
View more by Jean-Michel Basquiat →Valuation Analysis
Anchor and approach: The single most reliable market datum is the painting’s first public auction: Sotheby’s New York sold Versus Medici on 12 May 2021 with a price realized of USD 50,820,000 (hammer reported USD 44,000,000). [1] Using that documented sale as the primary anchor, I apply a comparables‑adjusted approach to define a practical market range today.
Comparable context: The Basquiat market is highly tiered: canonical 1982 works have set the ceiling (Untitled, 1982, sold 2017) and other major 1982–83 canvases trade in a band from roughly the low‑$40 millions into the $60–70M range depending on rarity and provenance. Notable anchors include Christie’s In This Case (May 2021) and Phillips’ 2024 sale of Untitled (ELMAR), which demonstrate vigorous demand for peak‑period canvases [2][3]. Larger multi‑panel or history/figure compositions have recently realized sums near the upper mid‑range (e.g., El Gran Espectaculo, 2023) and therefore define realistic upside under exceptional sale conditions [5]. The 2017 nine‑figure Untitled remains the market ceiling for Basquiat and is the primary reminder that the top of the market is very selective and driven by a handful of museum‑quality masterpieces [4].
Why USD 45–70M: The realized 2021 price establishes a comfortable floor; a prudent lower estimate (~USD 45M) reflects a conservative repositioning from that anchor after accounting for buyer’s premium, normal auction variability and typical market movement. The upper estimate (~USD 70M) describes an outcome in which the work benefits from exceptional pre‑sale positioning — complete catalogue‑raisonné citations, institutional loans/exhibition momentum, flawless condition (particularly the three‑panel joins and collage stability), and heated competitive bidding often facilitated by guarantees or irrevocable bids. Between these outcomes, lot‑specific factors (condition, any questions in the title chain, and the chosen sales route) will determine where the final hammer lands.
Practical next steps: To tighten this range, secure a professional condition/conservation report (with focus on joins and collaged elements), assemble full provenance and exhibition/literature citations as published in Sotheby’s lot notes and/or catalogues raisonnés, and evaluate sale strategy (marquee evening auction with guarantee vs targeted private sale). With those materials in hand, the likely sellable range will compress and the lot can be positioned to achieve results at or above the stated band. [1][2][3][4][5]
Key Valuation Factors
Art Historical Significance
High ImpactVersus Medici is dated 1982, the pivotal year in Basquiat’s career when his market and critical profile consolidated. Works from 1981–83 are considered his most desirable by collectors and institutions because they encapsulate his mature vocabulary—energetic mark‑making, layered text, and historical referencing. A triptych/three‑canvas structure with collage elements increases visual and scholarly interest: multi‑panel works tend to be treated as major statements and pull additional institutional attention. If this painting is reproduced in major monographs, included in retrospectives, or cited in catalogue raisonnés, its art‑historical weight becomes a material positive for market value.
Provenance & Exhibition History
High ImpactSotheby’s provenance notes record an early link to Larry Gagosian (sold from the artist’s studio in 1982), early ownership by Stéphane Janssen, and long‑term private ownership until the 2021 auction. That chain is strong and market‑supportive: documented, continuous provenance from a recognized blue‑chip dealer and a named early collector materially reduces transactional friction. Additional exhibition entries and catalogue citations listed by Sotheby’s further strengthen market confidence. Any gaps, conflicting ownership claims, or unresolved title issues would depress value; conversely, added museum loans or catalogue raisonné endorsements would drive price toward the top of the estimate range.
Condition & Materials
Medium ImpactThe work’s materials—acrylic, oilstick and paper collage on three joined canvases—require careful conservation review. Multi‑panel joins, paper collage adhesion, and oilstick stability are common attention points for 1980s mixed‑media Basquiats. A pristine, well‑documented conservation history is a value multiplier because it removes lot‑specific risk for buyers and institutions. Conversely, evidence of unstable collage, extensive restoration, or insecure joins (structural weakness) can subtract materially from hammer outcomes. Because we do not currently have a formal condition report, condition is a medium impact factor pending professional assessment.
Market Comparables & Liquidity
High ImpactDirect market comparables for 1982–83 Basquiats provide the clearest pricing context. Versus Medici’s 2021 realized price (~USD 50.82M) sits in the middle of a cluster defined by large mid‑1980s canvases that have traded between roughly USD 42M and USD 67M in recent years, while a few canonical works have set nine‑figure ceilings. These comparable sales show two things: (1) substantial, consistent buyer appetite for peak‑period Basquiats and (2) a wide spread in final prices driven by rarity, iconography and provenance. Versus Medici’s documented auction result therefore establishes a dependable market anchor.
Sale Venue & Market Timing
High ImpactRoute to market materially affects outcome. Evening auctions at major houses (Sotheby’s, Christie’s, Phillips) create the most competitive public theatre for Basquiat masterpieces and typically maximize final realizations—particularly with strong pre‑sale marketing, institutional interest, or guarantees. Private sales can be faster and discreet, but they often realize a narrower spread. Timing relative to major exhibitions, blockbuster retrospectives, or concentrated auction weeks also matters: offer windows that coincide with sustained museum programming around Basquiat works generally lift buyer engagement and realized prices.
Sale History
Artist studio / Larry Gagosian (private sale)
Private acquisition (from Stéphane Janssen)
Sotheby's, New York (Contemporary Art Evening Auction)
Jean-Michel Basquiat's Market
Jean‑Michel Basquiat is an established blue‑chip of the contemporary market; his peak‑period canvases (c.1981–83) consistently command the highest prices. The artist’s auction record (Untitled, 1982) set a nine‑figure ceiling, and subsequent marquee sales demonstrate sustained demand among institutions and private collectors. Recent years show a concentration of liquidity at the top end—major Basquiats remain highly sought after while mid‑market activity is more selective. Works on paper and smaller formats have also recorded significant prices, broadening collector entry points but leaving flagship canvases as the primary value drivers.
Comparable Sales
Untitled (1982, skull)
Jean-Michel Basquiat
Canonical 1982 Basquiat 'skull' masterpiece — same artist and period; serves as the market ceiling for 1982 works and a top‑tier benchmark.
$110.5M
2017, Sotheby's New York
~$140.0M adjusted
In This Case (1983)
Jean-Michel Basquiat
Major 1983 work sold in the same auction season as Versus Medici; comparable by period, scale and market prominence — helps define the high tier for 1981–83 paintings.
$93.1M
2021, Christie's New York
~$104.8M adjusted
El Gran Espectaculo (The Nile) (1983)
Jean-Michel Basquiat
Large multi‑panel history/figure work from 1983 — comparable in scale and narrative complexity to Versus Medici; useful for judging demand for large, museum‑quality 1982–83 works.
$67.1M
2023, Christie's New York
~$71.2M adjusted
Self‑Portrait as a Heel (Part Two) (1982)
Jean-Michel Basquiat
1982 single‑figure painting — close by date and subject scale to Versus Medici; its mid‑tier result shows the lower bound for important 1982 canvases.
$42.0M
2023, Sotheby's New York
~$44.6M adjusted
Untitled (ELMAR) (1982)
Jean-Michel Basquiat
1982 Basquiat sold in 2024 — strong recent result for a same‑year work at a major house; demonstrates ongoing appetite for high‑quality 1982 paintings near the $45M band.
$46.5M
2024, Phillips New York
~$47.9M adjusted
Current Market Trends
Market conditions are 'selectively strong': top‑tier Basquiat works remain liquid and capable of achieving high multi‑million outcomes, supported by museum interest and competitive bidding. Broader contemporary auction depth has been uneven, so lot‑specific quality, provenance and presentation now have outsized influence on final prices. Guarantees and strategic marketing continue to shape outcomes for marquee lots.
Sources
- Sotheby's — Versus Medici lot article and sale listing (May 12, 2021)
- Christie's — 'In This Case' sale results (May 11, 2021)
- Phillips — Basquiat masterworks press release (Untitled ELMAR, May 14, 2024)
- Sotheby's — Basquiat 'Untitled' (1982) auction record coverage (2017)
- Christie's — El Gran Espectaculo (The Nile) sale/press (May 2023)